Author Correction: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway.
Sci Rep
; 11(1): 22452, 2021 Nov 11.
Article
in En
| MEDLINE
| ID: mdl-34764341
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Sci Rep
Year:
2021
Document type:
Article